Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anzai, Y.
Right arrow Articles by Lufkin, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anzai, Y.
Right arrow Articles by Lufkin, R. B.

Radiology, Vol 192, 709-715, Copyright © 1994 by Radiological Society of North America


ARTICLES

Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer

Y Anzai, KE Blackwell, SL Hirschowitz, JW Rogers, Y Sato, WT Yuh, VM Runge, MR Morris, SJ McLachlan and RB Lufkin
Department of Radiological Sciences, University of California, Los Angeles 90024-1721.

PURPOSE: To investigate the efficacy of magnetic resonance (MR) imaging with dextran-coated superparamagnetic iron oxide in the differentiation of metastatic and benign nodes in patients with head and neck cancer. MATERIALS AND METHODS: MR imaging was performed before and after intravenous administration of iron oxide in 12 patients. Ninety-one pathologically proved nodes were visually analyzed, and 66 lymph nodes were quantitatively analyzed by measuring signal intensity in visually selected regions of interest. RESULTS: Forty of 42 histologically proved metastatic nodes and 41 of 49 benign nodes were detected, yielding 95% sensitivity and 84% specificity. The signal intensity ratio of benign nodes was substantially lower than that of metastatic nodes, indicating better differentiation of metastatic and benign nodes. Furthermore, 13 of 14 normal-sized nodes were detected. CONCLUSION: MR imaging with iron oxide can enable specific differentiation of metastatic and benign nodes in patients with head and neck cancer. This agent may potentially enhance the detection of metastatic lymph nodes and deserves further investigation.


This article has been cited by other articles:


Home page
RadiologyHome page
D. J. A. Margolis, J. M. Hoffman, R. J. Herfkens, R. B. Jeffrey, A. Quon, and S. S. Gambhir
Molecular Imaging Techniques in Body Imaging
Radiology, November 1, 2007; 245(2): 333 - 356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. Saksena, M. Harisinghani, P. Hahn, J. Kim, A. Saokar, B. King, and R. Weissleder
Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers.
Am. J. Roentgenol., December 1, 2006; 187(6): W582 - W588.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. H. Choi, M. H. Han, W. K. Moon, K. R. Son, J.-K. Won, J.-H. Kim, B. J. Kwon, D. G. Na, H.-J. Weinmann, and K.-H. Chang
Cervical Lymph Node Metastases: MR Imaging of Gadofluorine M and Monocrystalline Iron Oxide Nanoparticle-47 in a Rabbit Model of Head and Neck Cancer
Radiology, December 1, 2006; 241(3): 753 - 762.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Memarsadeghi, C. C. Riedl, A. Kaneider, A. Galid, M. Rudas, W. Matzek, and T. H. Helbich
Axillary Lymph Node Metastases in Patients with Breast Carcinomas: Assessment with Nonenhanced versus USPIO-enhanced MR Imaging.
Radiology, November 1, 2006; 241(2): 367 - 377.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
W. M. L. L. G. Deserno, M. G. Harisinghani, M. Taupitz, G. J. Jager, J. A. Witjes, P. F. Mulders, C. A. Hulsbergen van de Kaa, D. Kaufmann, and J. O. Barentsz
Urinary Bladder Cancer: Preoperative Nodal Staging with Ferumoxtran-10-enhanced MR Imaging
Radiology, November 1, 2004; 233(2): 449 - 456.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Torabi, S. L. Aquino, and M. G. Harisinghani
Current Concepts in Lymph Node Imaging
J. Nucl. Med., September 1, 2004; 45(9): 1509 - 1518.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
B. Misselwitz, J. Platzek, and H.-J. Weinmann
Early MR Lymphography with Gadofluorine M in Rabbits
Radiology, June 1, 2004; 231(3): 682 - 688.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Floris, E. L. A. Blezer, G. Schreibelt, E. Dopp, S. M. A. van der Pol, I. L. Schadee-Eestermans, K. Nicolay, C. D. Dijkstra, and H. E. de Vries
Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: A quantitative MRI study
Brain, March 1, 2004; 127(3): 616 - 627.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Y. Anzai, C. W. Piccoli, E. K. Outwater, W. Stanford, D. A. Bluemke, P. Nurenberg, S. Saini, K. R. Maravilla, D. E. Feldman, U. P. Schmiedl, et al.
Evaluation of Neck and Body Metastases to Nodes with Ferumoxtran 10-enhanced MR Imaging: Phase III Safety and Efficacy Study
Radiology, September 1, 2003; 228(3): 777 - 788.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. G. Harisinghani, J. Barentsz, P. F. Hahn, W. M. Deserno, S. Tabatabaei, C. H. van de Kaa, J. de la Rosette, and R. Weissleder
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
N. Engl. J. Med., June 19, 2003; 348(25): 2491 - 2499.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. H. Kaim, T. Wischer, T. O'Reilly, G. Jundt, J. Frohlich, G. K. von Schulthess, and P. R. Allegrini
MR Imaging with Ultrasmall Superparamagnetic Iron Oxide Particles in Experimental Soft-Tissue Infections in Rats
Radiology, December 1, 2002; 225(3): 808 - 814.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. C. A. Michel, T. M. Keller, J. M. Frohlich, D. Fink, R. Caduff, B. Seifert, B. Marincek, and R. A. Kubik-Huch
Preoperative Breast Cancer Staging: MR Imaging of the Axilla with Ultrasmall Superparamagnetic Iron Oxide Enhancement
Radiology, November 1, 2002; 225(2): 527 - 536.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
P. A Hudgins, Y. Anzai, M. R Morris, and M. A Lucas
Ferumoxtran-10, A Superparamagnetic Iron Oxide as a Magnetic Resonance Enhancement Agent for Imaging Lymph Nodes: A Phase 2 Dose Study
AJNR Am. J. Neuroradiol., April 1, 2002; 23(4): 649 - 656.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. Schaefer-Prokop and M. Prokop
New imaging techniques in the treatment guidelines for lung cancer
Eur. Respir. J., February 1, 2002; 19(35_suppl): 71S - 83s.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. G. Ruehm, T. Schroeder, and J. F. Debatin
Interstitial MR Lymphography with Gadoterate Meglumine: Initial Experience in Humans
Radiology, September 1, 2001; 220(3): 816 - 821.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kanno, Y.-J. L. Wu, P. C. Lee, S. J. Dodd, M. Williams, B. P. Griffith, and C. Ho
Macrophage Accumulation Associated With Rat Cardiac Allograft Rejection Detected by Magnetic Resonance Imaging With Ultrasmall Superparamagnetic Iron Oxide Particles
Circulation, August 21, 2001; 104(8): 934 - 938.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. G. Ruehm, C. Corot, and J. F. Debatin
Interstitial MR Lymphography with a Conventional Extracellular Gadolinium-based Agent: Assessment in Rabbits
Radiology, March 1, 2001; 218(3): 664 - 669.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Kanno, P. C. Lee, S. J. Dodd, M. Williams, B. P. Griffith, and C. Ho
A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection
J. Thorac. Cardiovasc. Surg., November 1, 2000; 120(5): 923 - 934.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
V. Dousset, L. Ballarino, C. Delalande, M. Coussemacq, P. Canioni, K. G. Petry, and J.-M. Caillé
Comparison of Ultrasmall Particles of Iron Oxide (USPIO)-Enhanced T2-Weighted, Conventional T2-Weighted, and Gadolinium-Enhanced T1-Weighted MR Images in Rats with Experimental Autoimmune Encephalomyelitis
AJNR Am. J. Neuroradiol., February 1, 1999; 20(2): 223 - 227.
[Abstract] [Full Text]


Home page
RadiologyHome page
M. G. Mack, J. O. Balzer, R. Straub, K. Eichler, and T. J. Vogl
Superparamagnetic Iron Oxide-enhanced MR Imaging of Head and Neck Lymph Nodes
Radiology, January 1, 2002; 222(1): 239 - 244.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1994 by the Radiological Society of North America.